How Genetic Discoveries Lead to Parkinson's Therapies

How Genetic Discoveries Lead to Parkinson's Therapies Thursday, July 18, 2019, 12 to 1 p.m. ET This month, we'll replay a popular webinar where our panelists will discuss ongoing trials targeting genetic links to Parkinson's (alpha-synuclein, GBA and LRRK2) and how we go from discovering genes to creating precision therapies. Plus, we will talk about why you should participate in genetic research even if you don't carry a known Parkinson's genetic mutation. MJFF staff will be on hand to answer your questions through the webinar portal. Watch previous Third Thursdays Webinars at www.michaeljfox.org/webinars.   The MJFF webinar series has been made possible through the leadership of members of ourParkinson's Disease Education Consortium in conjunction with The Albert B. Glickman Parkinson's Disease Education Program. Support from these partners allows us to furnish high-quality educational content to the Parkinson's community while maintaining our commitment to allocate donor dollars to high-impact research. Editorial control of all content published by The Michael J. Fox Foundation rests solely with the Foundation.